MILabs Launches New Molecular Imaging Product Line at the European Association of Nuclear Medicine Annual Meeting

MILabs BV has launched a complete new preclinical product line at the 2014 Annual European Association of Nuclear Medicine Meeting in Gothenburg, Sweden, October 18-22. It consists of the new 4-series comprising U-SPECT4, U-SPECT⁴CT, VECTor⁴ and VECTor⁴CT incorporating significant improvements over the former PLUS-series. The 4-series carries even further the tradition of MILabs to deliver the best SPECT and PET image resolution available in the market.

The new systems are more compact and include a dramatically improved X-Ray CT subsystem with reduced radiation dose, increased resolution and speed. The CT subsystem comes at three different resolution levels. The high resolution versions have significant added value for application areas such as in vivo bone, cancer and arthritis research.

“Our customers are highly enthusiastic about the integrated low dose CT units and we are pleased to offer them dramatically improved resolution as well“, says Frederik Beekman, CEO/CSO of MILabs. This new generation U-SPECT⁴CT and VECTor⁴CT brings MILabs even further ahead in terms of combined ultra-high resolution functional and anatomical nuclear imaging. MILabs expects that the next generation U-SPECT⁴, U-SPECT⁴CT, VECTor⁴ and VECTor⁴CT systems will further accelerate the rapid growth of MILabs’ global customer base.